Good Pharmacovigilance Practice

Good Pharmacovigilance Practices (GVP) begins with the acquisition of complete data from spontaneous adverse event reports. GVP characterizes the adverse event details, baseline patient characteristics, therapy details, diagnosis of the events and clinical course of the event. The role of Good Pharmacovigilance Practice and Pharmacoepidemology in Risk Management is mainly to  increase the probability of beneficial effects of a drug in a population than the probability of adverse effects and to maintain the Good Reporting Practices by avoiding the major problems in risk management. Also it is important to concentrate on Signal investigation by gathering the information on new or unknown drug effects that is potentially caused by a medicine and that finally should lead to ensuring safety. The pharmacovigilance and clinical trials services providing companies should have the Pharmacovigilance certification .

  • Role of pharmacovigilance and pharmacoepidemiology in risk management
  • Good reporting practices
  • Signal investigation via observational studies
  • Interpreting safety signals
  • Randomized clinical trials
  • Ethical and social aspects of drug use

Related Conference of Good Pharmacovigilance Practice

July 03-05, 2017

4th Annual Congress on Drug Discovery & Designing

Bangkok, Thailand
August 10-12, 2017

8th Asian Biologics and Biosimilars Congress

Beijing, China
Sep 20-21, 2017

10th Pharmacovigilance Congress

Charlotte, North Carolina, USA
September 25-26, 2017(10 Plenary Forums- 1 Event)

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

Chicago, Illinois, USA
September 25-26, 2017
(10 Plenary Forums - 1Event)

6th International Conference and Exhibition on GMP, GCP & Quality Control

Chicago, Illinois, USA
October 02-04, 2017

World Congress on Antibiotics: R&D, Market

Atlanta, USA
October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
Dec 14-16, 2017

7th Global Mass Spectrometry Congress

Dubai, UAE

Good Pharmacovigilance Practice Conference Speakers

Recommended Sessions

Related Journals

Are you interested in